{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:46:34Z","timestamp":1787319994798,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11030-022-10556-9","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T05:02:41Z","timestamp":1667278961000},"page":"2273-2296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-003X","authenticated-orcid":false,"given":"Hezha O.","family":"Rasul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhtyar K.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dlzar D.","family":"Ghafour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Kivrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"10556_CR1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol 95:20211033","journal-title":"Br J Radiol"},{"key":"10556_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.7150\/jca.13141","volume":"7","author":"X Dai","year":"2016","unstructured":"Dai X, Xiang L, Li T, Bai Z (2016) Cancer hallmarks, biomarkers and breast cancer molecular subtypes. J Cancer 7:1281","journal-title":"J Cancer"},{"key":"10556_CR3","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1200\/JCO.2005.66.130","volume":"23","author":"S Chan","year":"2005","unstructured":"Chan S, Scheulen ME, Johnston S, Mross K, Cardoso F, Dittrich C, Eiermann W, Hess D, Morant R, Semiglazov V (2005) Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol 23:5314\u20135322. https:\/\/doi.org\/10.1200\/JCO.2005.66.130","journal-title":"J Clin Oncol"},{"key":"10556_CR4","doi-asserted-by":"publisher","unstructured":"M. Castellanos, C. Gubern, E. Kadar, mTOR: Exploring a New Potential Therapeutic Target for Stroke, in: Mol. to Med. with MTOR, Elsevier, 2016: pp. 105\u2013122. https:\/\/doi.org\/10.1016\/B978-0-12-802733-2.00012-8.","DOI":"10.1016\/B978-0-12-802733-2.00012-8"},{"key":"10556_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2319-4170.110365","volume":"36","author":"M Wong","year":"2013","unstructured":"Wong M (2013) Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J 36:1","journal-title":"Biomed J"},{"key":"10556_CR6","first-page":"81","volume-title":"Inflammation, Immunity, Infect","author":"KA Tekirdag","year":"2015","unstructured":"Tekirdag KA, Ozturk DG, Gozuacik D (2015) Regulation of Autophagy by microRNAs. In: Cancer A, Pathol O (eds) Inflammation, Immunity, Infect. Elsevier, Aging, pp 81\u2013101"},{"key":"10556_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"key":"10556_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-020-00396-1","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou Z, Tao T, Li H, Zhu X (2020) mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci 10:1\u201311. https:\/\/doi.org\/10.1186\/s13578-020-00396-1","journal-title":"Cell Biosci"},{"key":"10556_CR9","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1001\/jamaoncol.2019.2525","volume":"5","author":"N Unni","year":"2019","unstructured":"Unni N, Arteaga CL (2019) Is dual mTORC1 and mTORC2 therapeutic blockade clinically feasible in cancer? JAMA Oncol 5:1564\u20131565. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2525","journal-title":"JAMA Oncol"},{"key":"10556_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C (2022) PI3K\/Akt\/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front Oncol 12:819128","journal-title":"Front Oncol"},{"key":"10556_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606\u2013619. https:\/\/doi.org\/10.1038\/nrg1879","journal-title":"Nat Rev Genet"},{"key":"10556_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1096502","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science. https:\/\/doi.org\/10.1126\/science.1096502","journal-title":"Science"},{"key":"10556_CR13","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3109\/10428194.2011.580478","volume":"52","author":"J Gera","year":"2011","unstructured":"Gera J, Lichtenstein A (2011) The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma. Leuk Lymphoma 52:1857\u20131866. https:\/\/doi.org\/10.3109\/10428194.2011.580478","journal-title":"Leuk Lymphoma"},{"key":"10556_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","volume":"1804","author":"RJO Dowling","year":"2010","unstructured":"Dowling RJO, Topisirovic I, Fonseca BD, Sonenberg N (2010) Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta 1804:433\u2013439. https:\/\/doi.org\/10.1016\/j.bbapap.2009.12.001","journal-title":"Biochim Biophys Acta"},{"key":"10556_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/molecules26041103","volume":"26","author":"S Vittorio","year":"2021","unstructured":"Vittorio S, Gitto R, Adornato I, Russo E, De Luca L (2021) In silico strategy for targeting the mTOR kinase at rapamycin binding site by small molecules. Molecules 26:1103. https:\/\/doi.org\/10.3390\/molecules26041103","journal-title":"Molecules"},{"key":"10556_CR16","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.3390\/molecules25173991","volume":"25","author":"NN Zulkipli","year":"2020","unstructured":"Zulkipli NN, Zakaria R, Long I, Abdullah SF, Muhammad EF, Wahab HA, Sasongko TH (2020) In silico analyses and cytotoxicity study of asiaticoside and asiatic acid from malaysian plant as potential mTOR inhibitors. Molecules 25:3991. https:\/\/doi.org\/10.3390\/molecules25173991","journal-title":"Molecules"},{"key":"10556_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21\u201335. https:\/\/doi.org\/10.1038\/nrm3025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10556_CR18","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"key":"10556_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann D, Park S, Hall MN (2018) mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer 18:744\u2013757. https:\/\/doi.org\/10.1038\/s41568-018-0074-8","journal-title":"Nat Rev Cancer"},{"key":"10556_CR20","first-page":"383","volume":"7","author":"SH Hare","year":"2017","unstructured":"Hare SH, Harvey AJ (2017) mTOR function and therapeutic targeting in breast cancer. Am J Cancer Res 7:383","journal-title":"Am J Cancer Res"},{"key":"10556_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y (2019) Targeting mTOR for cancer therapy. J Hematol Oncol 12:1\u201319. https:\/\/doi.org\/10.1186\/s13045-019-0754-1","journal-title":"J Hematol Oncol"},{"key":"10556_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0378-8741(03)00231-9","volume":"88","author":"N Adhirajan","year":"2003","unstructured":"Adhirajan N, Kumar TR, Shanmugasundaram N, Babu M (2003) In vivo and in vitro evaluation of hair growth potential of Hibiscus rosa-sinensis Linn. J Ethnopharmacol 88:235\u2013239","journal-title":"J Ethnopharmacol"},{"key":"10556_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0378-8741(98)00157-3","volume":"65","author":"MH Faraji","year":"1999","unstructured":"Faraji MH, Tarkhani AHH (1999) The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol 65:231\u2013236","journal-title":"J Ethnopharmacol"},{"key":"10556_CR24","unstructured":"P.C. Ochani, P. D\u2019Mello, Antioxidant and antihyperlipidemic activity of Hibiscus sabdariffa Linn. leaves and calyces extracts in rats (2009)."},{"key":"10556_CR25","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.3390\/nu7075065","volume":"7","author":"C-T Chiu","year":"2015","unstructured":"Chiu C-T, Chen J-H, Chou F-P, Lin H-H (2015) Hibiscus sabdariffa leaf extract inhibits human prostate cancer cell invasion via down-regulation of Akt\/NF-\u03baB\/MMP-9 pathway. Nutrients 7:5065\u20135087","journal-title":"Nutrients"},{"key":"10556_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0006-2952(00)00322-1","volume":"60","author":"T-H Tseng","year":"2000","unstructured":"Tseng T-H, Kao T-W, Chu C-Y, Chou F-P, Lin W-L, Wang C-J (2000) Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochem Pharmacol 60:307\u2013315","journal-title":"Biochem Pharmacol"},{"key":"10556_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cbi.2006.10.011","volume":"165","author":"H-H Lin","year":"2007","unstructured":"Lin H-H, Chen J-H, Kuo W-H, Wang C-J (2007) Chemopreventive properties of Hibiscus sabdariffa L. on human gastric carcinoma cells through apoptosis induction and JNK\/p38 MAPK signaling activation. Chem Biol Interact 165:59\u201375","journal-title":"Chem Biol Interact"},{"key":"10556_CR28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/01635581.2016.1208830","volume":"68","author":"A Malacrida","year":"2016","unstructured":"Malacrida A, Maggioni D, Cassetti A, Nicolini G, Cavaletti G, Miloso M (2016) Antitumoral effect of Hibiscus sabdariffa on human squamous cell carcinoma and multiple myeloma cells. Nutr Cancer 68:1161\u20131170","journal-title":"Nutr Cancer"},{"key":"10556_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-019-2505-9","volume":"19","author":"C Nguyen","year":"2019","unstructured":"Nguyen C, Baskaran K, Pupulin A, Ruvinov I, Zaitoon O, Grewal S, Scaria B, Mehaidli A, Vegh C, Pandey S (2019) Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics. BMC Complement Altern Med 19:1\u201314","journal-title":"BMC Complement Altern Med"},{"key":"10556_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-015-0592-9","volume":"15","author":"R-J Hsu","year":"2015","unstructured":"Hsu R-J, Hsu Y-C, Chen S-P, Fu C-L, Yu J-C, Chang F-W, Chen Y-H, Liu J-M, Ho J-Y, Yu C-P (2015) The triterpenoids of Hibiscus syriacus induce apoptosis and inhibit cell migration in breast cancer cells. BMC Complement Altern Med 15:1\u20139","journal-title":"BMC Complement Altern Med"},{"key":"10556_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.micpath.2018.08.003","volume":"123","author":"S Vijayakumar","year":"2018","unstructured":"Vijayakumar S, Yabesh JEM, Arulmozhi P, Praseetha PK (2018) Identification and isolation of antimicrobial compounds from the flower extract of Hibiscus rosa-sinensis L.: in silico and in vitro approaches. Microb Pathog 123:527\u2013535","journal-title":"Microb Pathog"},{"key":"10556_CR32","doi-asserted-by":"crossref","unstructured":"J.Y. Salib, Polyphenolic Compounds from Flowers of Hibiscus: Characterization and Bioactivity, in: Polyphenols in Plants, Elsevier, 2014: pp. 231\u2013239.","DOI":"10.1016\/B978-0-12-397934-6.00012-7"},{"key":"10556_CR33","first-page":"756","volume":"6","author":"A-M Ateya","year":"2012","unstructured":"Ateya A-M, El Sayed ZI, Fekry M (2012) Chemical constituents, cytotoxicity, anti-oxidant, hypoglycemic and antihypertensive activities of Egyptian Hibiscus trionum. Aust J Basic Appl Sci 6:756\u2013766","journal-title":"Aust J Basic Appl Sci"},{"key":"10556_CR34","unstructured":"J.F. Morton, Renewed interest in Roselle (Hibiscus sabdariffa l.), the long-forgotten\" florida cranberry\", in: Proc. Florida State Hortic. Soc., 1974: pp. 415\u2013425."},{"key":"10556_CR35","doi-asserted-by":"crossref","unstructured":"I.A. Ross, Hibiscus sabdariffa, in: Med. Plants World, Springer, 2003: pp. 267\u2013275.","DOI":"10.1007\/978-1-59259-365-1_13"},{"key":"10556_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1414-431x2020e10889","volume":"54","author":"LTM Ngan","year":"2021","unstructured":"Ngan LTM, Tan MT, Hoang NVM, Thanh DT, Linh NTT, Hoa TTH, Nuong NTM, Hieu TT (2021) Antibacterial activity of Hibiscus rosa-sinensis L. red flower against antibiotic-resistant strains of Helicobacter pylori and identification of the flower constituents. Brazilian J. Med. Biol. Res. 54:1","journal-title":"Brazilian J. Med. Biol. Res."},{"key":"10556_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1515\/znc-2011-9-1003","volume":"66","author":"JY Salib","year":"2011","unstructured":"Salib JY, Daniel EN, Hifnawy MS, Azzam SM, Shaheed IB, Abdel-Latif SM (2011) Polyphenolic compounds from flowers of Hibiscus rosa-sinensis Linn. and their inhibitory effect on alkaline phosphatase enzyme activity in vitro. Zeitschrift F\u00fcr Naturforsch C. 66:453\u2013459","journal-title":"Zeitschrift F\u00fcr Naturforsch C."},{"key":"10556_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2019.103994","volume":"24","author":"SP Gandhi","year":"2019","unstructured":"Gandhi SP, Lokhande KB, Swamy VK, Nanda RK, Chitlange SS (2019) Computational data of phytoconstituents from Hibiscus rosa-sinensis on various anti-obesity targets. Data Br 24:103994","journal-title":"Data Br"},{"key":"10556_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0028-1097275","volume":"36","author":"RB Salama","year":"1979","unstructured":"Salama RB, Ibrahim SA (1979) Ergosterol in Hibiscus sabdariffa seed oil. Planta Med 36:221\u2013222","journal-title":"Planta Med"},{"key":"10556_CR40","doi-asserted-by":"crossref","unstructured":"B.H. Ali, N. Al Wabel, G. Blunden, Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review, Phyther. Res. An Int. J. Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 19 (2005) 369\u2013375.","DOI":"10.1002\/ptr.1628"},{"key":"10556_CR41","doi-asserted-by":"crossref","unstructured":"A.M. Osman, M. El-Garby Younes, A. Mokhtar, Sitosterol-bD-galactoside from Hibiscus sabdariffa, Phytochem. (1975).","DOI":"10.1016\/0031-9422(75)83056-1"},{"key":"10556_CR42","first-page":"1","volume":"2","author":"AM Osman","year":"1975","unstructured":"Osman AM, Younes MeG, Mokhtar A (1975) Chemical examination of local plants. VIII. Comparative studies between constituents of different parts of Egyptian Hibiscus sabdariffa. Indian J Chem 2:1","journal-title":"Indian J Chem"},{"key":"10556_CR43","doi-asserted-by":"crossref","unstructured":"C.T. Du, F.J. Francis, Anthocyanins of roselle (Hibiscus sabdariffa, L.), J. Food Sci. 38 (1973) 810\u2013812.","DOI":"10.1111\/j.1365-2621.1973.tb02081.x"},{"key":"10556_CR44","first-page":"292","volume":"1","author":"G Reaubourg","year":"1940","unstructured":"Reaubourg G, Monceaux RH (1940) The chemical, botanical and pharmacological characteristics of the karkade (rosella) Hibiscus sabdariffa (gossypifolius). J Pharm Chim 1:292","journal-title":"J Pharm Chim"},{"key":"10556_CR45","unstructured":"Anon, Food Coloring Agents from Hibiscus Flowers, Patent-Japan Kokai Tokkyo Koho-81. 141 (1981) 3585."},{"key":"10556_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3358\/shokueishi.32.301","volume":"32","author":"K Sato","year":"1991","unstructured":"Sato K, Goda Y, Yoshihira K, Noguchi H (1991) Structure and contents of main coloring constituents in the calyces of Hibiscus sabdariffa and commercial roselle color. Food Hyg. Saf. Sci. 32:301\u2013307","journal-title":"Food Hyg. Saf. Sci."},{"key":"10556_CR47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0031-9422(01)00263-1","volume":"58","author":"G Blunden","year":"2001","unstructured":"Blunden G, Patel AV, Armstrong NJ, Gorham J (2001) Betaine distribution in the Malvaceae. Phytochemistry 58:451\u2013454","journal-title":"Phytochemistry"},{"key":"10556_CR48","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/jf00123a022","volume":"32","author":"H Al-Wandawi","year":"1984","unstructured":"Al-Wandawi H, Al-Shaikhly K, Abdul-Rahman M (1984) Roselle seeds: a new protein source. J Agric Food Chem 32:510\u2013512","journal-title":"J Agric Food Chem"},{"key":"10556_CR49","unstructured":"D.W. Bishay, C.S. Gomaa, Comparative chromatographic studies of oils of some medicinal seeds [Cassia acutifolia, C. obovata, Fenugreek, Hibiscus sabdariffa, Colchicum automnale, Citrullus colocynth; Egypt], Egypt. J. Pharm. Sci. (1976)."},{"key":"10556_CR50","unstructured":"M.S. Karawya, M.G. Ghourab, I.M. El Shami, Study of anthocyanin content of karkadeh, Hibiscus sabdariffa [Egypt]., Egypt. J. Pharm. Sci. (1975)."},{"key":"10556_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jsfa.2740300412","volume":"30","author":"MU Ahmad","year":"1979","unstructured":"Ahmad MU, Husain SK, Ahmad I, Osman SM (1979) Hibiscus sabdariffa seed oil: a re-investigation. J Sci Food Agric 30:424\u2013428","journal-title":"J Sci Food Agric"},{"key":"10556_CR52","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/molecules22101696","volume":"22","author":"STS Hassan","year":"2017","unstructured":"Hassan STS, \u0160vajdlenka E (2017) Biological evaluation and molecular docking of protocatechuic acid from Hibiscus sabdariffa L. as a potent urease inhibitor by an ESI-MS based method. Molecules 22:1696\u20131699","journal-title":"Molecules"},{"key":"10556_CR53","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.tiv.2007.06.004","volume":"21","author":"RM Rosa","year":"2007","unstructured":"Rosa RM, Moura DJ, Melecchi MIS, dos Santos RS, Richter MF, Camarao EB, Henriques JAP, de Paula Ramos ALL, Saffi J (2007) Protective effects of Hibiscus tiliaceus L. methanolic extract to V79 cells against cytotoxicity and genotoxicity induced by hydrogen peroxide and tert-butyl-hydroperoxide. Toxicol. Vitr. 21:1442\u20131452","journal-title":"Toxicol. Vitr."},{"key":"10556_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.53879\/id.54.10.11189","volume":"54","author":"M Ali","year":"2017","unstructured":"Ali M, Alam P, Singh V, Jameel M, Sultana S (2017) Phytochemical investigations of the leaves and flowers of Hibiscus rosa-sinensis L. Indian Drugs 54:30\u201337","journal-title":"Indian Drugs"},{"key":"10556_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"10556_CR56","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1128\/MCB.00678-12","volume":"33","author":"AM M\u00e4rz","year":"2013","unstructured":"M\u00e4rz AM, Fabian A-K, Kozany C, Bracher A, Hausch F (2013) Large FK506-binding proteins shape the pharmacology of rapamycin. Mol Cell Biol 33:1357\u20131367. https:\/\/doi.org\/10.1128\/MCB.00678-12","journal-title":"Mol Cell Biol"},{"key":"10556_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"2021","key":"10556_CR58","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B (2021) PubChem in 2011:new data content and improved web interfaces. Nucleic Acids Res 49(2021):D1388\u2013D1395. https:\/\/doi.org\/10.1093\/nar\/gkaa971","journal-title":"Nucleic Acids Res"},{"key":"10556_CR59","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"10556_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:1\u201314. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"10556_CR61","unstructured":"Chemaxon, Chemicalize was used for [prediction of microspecies distribution] (2022). https:\/\/chemicalize.com\/app\/calculation."},{"key":"10556_CR62","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1021\/ci900172h","volume":"49","author":"AP Harding","year":"2009","unstructured":"Harding AP, Wedge DC, Popelier PLA (2009) p K a prediction from \u201cquantum chemical topology\u201d descriptors. J Chem Inf Model 49:1914\u20131924. https:\/\/doi.org\/10.1021\/ci900172h","journal-title":"J Chem Inf Model"},{"key":"10556_CR63","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11095-013-1232-z","volume":"31","author":"L Settimo","year":"2014","unstructured":"Settimo L, Bellman K, Knegtel R (2014) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharm Res 31:1082\u20131095. https:\/\/doi.org\/10.1007\/s11095-013-1232-z","journal-title":"Pharm Res"},{"key":"10556_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-021-05010-w","volume":"28","author":"HO Rasul","year":"2022","unstructured":"Rasul HO, Aziz BK, Ghafour DD, Kivrak A (2022) In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer. J Mol Model 28:1\u201318. https:\/\/doi.org\/10.1007\/s00894-021-05010-w","journal-title":"J Mol Model"},{"key":"10556_CR65","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82\u201392","journal-title":"CCP4 Newsl Protein Crystallogr"},{"key":"10556_CR66","unstructured":"Molinspiration Cheminformatics, Nov. Ulica. (n.d.) Slovak Republic. https:\/\/www.molinspiration.com\/."},{"key":"10556_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong J, Wang N-N, Yao Z-J, Zhang L, Cheng Y, Ouyang D, Lu A-P, Cao D-S (2018) ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform 10:1\u201311. https:\/\/doi.org\/10.1186\/s13321-018-0283-x","journal-title":"J Cheminform"},{"key":"10556_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab255","author":"G Xiong","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A (2021) ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkab255","journal-title":"Nucleic Acids Res"},{"key":"10556_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"10556_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235\u2013249. https:\/\/doi.org\/10.1016\/S1056-8719(00)00107-6","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10556_CR71","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1021\/tx900189p","volume":"22","author":"H Zhu","year":"2009","unstructured":"Zhu H, Martin TM, Ye L, Sedykh A, Young DM, Tropsha A (2009) Quantitative structure\u2212activity relationship modeling of rat acute toxicity by oral exposure. Chem Res Toxicol 22:1913\u20131921. https:\/\/doi.org\/10.1021\/tx900189p","journal-title":"Chem Res Toxicol"},{"key":"10556_CR72","unstructured":"SeeSAR version 12.0.1, BioSolveIT GmbH, Sankt Augustin, Germany, 2022. www.biosolveit.de\/SeeSAR (2022). www.biosolveit.de\/SeeSAR."},{"key":"10556_CR73","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10822-011-9531-0","volume":"26","author":"N Schneider","year":"2012","unstructured":"Schneider N, Hindle S, Lange G, Klein R, Albrecht J, Briem H, Beyer K, Clau\u00dfen H, Gastreich M, Lemmen C (2012) Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function. J Comput Aided Mol Des 26:701\u2013723","journal-title":"J Comput Aided Mol Des"},{"key":"10556_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10822-012-9626-2","volume":"27","author":"N Schneider","year":"2013","unstructured":"Schneider N, Lange G, Hindle S, Klein R, Rarey M (2013) A consistent description of HYdrogen bond and DEhydration energies in protein\u2013ligand complexes: methods behind the HYDE scoring function. J Comput Aided Mol Des 27:15\u201329","journal-title":"J Comput Aided Mol Des"},{"key":"10556_CR75","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1021\/jm3016816","volume":"56","author":"C Sch\u00e4rfer","year":"2013","unstructured":"Sch\u00e4rfer C, Schulz-Gasch T, Ehrlich H-C, Guba W, Rarey M, Stahl M (2013) Torsion angle preferences in druglike chemical space: a comprehensive guide. J Med Chem 56:2016\u20132028","journal-title":"J Med Chem"},{"key":"10556_CR76","unstructured":"S. Release, 3: Desmond molecular dynamics system, DE Shaw research, New York, NY, 2017, Maest. Interoperability Tools. Schr\u00f6dinger, New York (2017)."},{"key":"10556_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10475-9","author":"HO Rasul","year":"2022","unstructured":"Rasul HO, Aziz BK, Ghafour DD, Kivrak A (2022) Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-022-10475-9","journal-title":"Mol Divers"},{"key":"10556_CR78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.compbiolchem.2016.08.007","volume":"64","author":"Y Ding","year":"2016","unstructured":"Ding Y, Fang Y, Moreno J, Ramanujam J, Jarrell M, Brylinski M (2016) Assessing the similarity of ligand binding conformations with the Contact Mode Score. Comput Biol Chem 64:403\u2013413","journal-title":"Comput Biol Chem"},{"key":"10556_CR79","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/molecules21111575","volume":"21","author":"MJ Garc\u00eda-Godoy","year":"2016","unstructured":"Garc\u00eda-Godoy MJ, L\u00f3pez-Camacho E, Garc\u00eda-Nieto J, Nebro AJ, Aldana-Montes JF (2016) Molecular docking optimization in the context of multi-drug resistant and sensitive EGFR mutants. Molecules 21:1575","journal-title":"Molecules"},{"key":"10556_CR80","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/90761","volume":"19","author":"J Hodgson","year":"2001","unstructured":"Hodgson J (2001) ADMET\u2014turning chemicals into drugs. Nat Biotechnol 19:722\u2013726. https:\/\/doi.org\/10.1038\/90761","journal-title":"Nat Biotechnol"},{"key":"10556_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068237","volume":"8","author":"A Beig","year":"2013","unstructured":"Beig A, Agbaria R, Dahan A (2013) Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations. PLoS ONE 8:e68237. https:\/\/doi.org\/10.1371\/journal.pone.0068237","journal-title":"PLoS ONE"},{"key":"10556_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/9780470915110","volume-title":"ADMET for medicinal chemists: a practical guide","author":"K Tsaioun","year":"2011","unstructured":"Tsaioun K, Kates SA (2011) ADMET for medicinal chemists: a practical guide. Wiley, New York"},{"key":"10556_CR83","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1021\/acs.jcim.9b00801","volume":"59","author":"Z Wu","year":"2019","unstructured":"Wu Z, Lei T, Shen C, Wang Z, Cao D, Hou T (2019) ADMET evaluation in drug discovery. 19. Reliable prediction of human cytochrome P450 inhibition using artificial intelligence approaches. J Chem Inf Model 59:4587\u20134601. https:\/\/doi.org\/10.1021\/acs.jcim.9b00801","journal-title":"J Chem Inf Model"},{"key":"10556_CR84","first-page":"885","volume":"3","author":"I Reulecke","year":"2008","unstructured":"Reulecke I, Lange G, Albrecht J, Klein R, Rarey M (2008) Towards an integrated description of hydrogen bonding and dehydration: decreasing false positives in virtual screening with the HYDE scoring function. ChemMedChem Chem Enabling Drug Discov 3:885\u2013897","journal-title":"ChemMedChem Chem Enabling Drug Discov"},{"key":"10556_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez L (2015) Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS ONE 10:e0119264. https:\/\/doi.org\/10.1371\/journal.pone.0119264","journal-title":"PLoS ONE"},{"key":"10556_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05641","volume":"6","author":"R Alnajjar","year":"2020","unstructured":"Alnajjar R, Mostafa A, Kandeil A, Al-Karmalawy AA (2020) Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease. Heliyon 6:e05641. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05641","journal-title":"Heliyon"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10556-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T08:38:37Z","timestamp":1695631117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10556"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10556-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest declared by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studied with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}